“NACI Recommendations for 2022-2023 Season: Annual Influenza Vaccination with Supemtek™ and Flucelvax® Quad for Certain Age Groups and COVID-19 Considerations”

https://pubmed.ncbi.nlm.nih.gov/38116046

The National Advisory Committee on Immunization (NACI) recommends annual influenza vaccination for individuals aged six months and older, with updated considerations for the 2022-2023 season including the use of Supemtek™ and Flucelvax® Quad vaccines for certain age groups and incorporation of guidance in the context of COVID-19.